Offerings // BioLineRx Ltd.

BLRX offering history

Every offering-related filing in BioLineRx Ltd.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 617 filings back to Sep 24, 2010.

Last executed offering
Aug 31, 2026
424B5 — priced deal (shares or notes)
Last registration (announced)
Sep 25, 2026
F-1 — capacity, not a sale
Executed, last 12 months
1
424B pricings + 8-K 3.02 sales
Registered, last 12 months
1
S-1/S-3/F-series registrations
DateFilingWhat it means
Oct 2, 2026424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Oct 2, 2026EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Sep 25, 2026F-1 →REGISTEREDF-1 registration — capacity to sell shares, not a sale yet
Aug 31, 2026424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jul 25, 2025424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Apr 11, 2025424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jan 7, 2025424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Nov 21, 2024424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Apr 1, 2024424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jan 5, 2024EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Dec 29, 2023F-3 →REGISTEREDF-3 registration — capacity to sell shares, not a sale yet
Sep 20, 2022424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Sep 3, 2021424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Feb 24, 2021EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Jan 21, 2021424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jan 20, 2021FWP →MARKETINGFree-writing prospectus — offering being marketed
Jan 19, 2021424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jan 19, 2021FWP →MARKETINGFree-writing prospectus — offering being marketed
Jan 11, 2021EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Dec 31, 2020424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Dec 31, 2020F-3 →REGISTEREDF-3 registration — capacity to sell shares, not a sale yet
Nov 13, 2020424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Sep 25, 2020424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Aug 12, 2020EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Jul 2, 2020424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Jul 2, 2020EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Jun 26, 2020F-1 →REGISTEREDF-1 registration — capacity to sell shares, not a sale yet
Jun 3, 2020424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
May 28, 2020424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Apr 17, 2020424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Feb 13, 2019EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Feb 5, 2019424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Feb 4, 2019424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Dec 26, 2018F-3 →REGISTEREDF-3 registration — capacity to sell shares, not a sale yet
Jan 19, 2018F-3/A →REGISTEREDF-3/A registration — capacity to sell shares, not a sale yet
Jan 19, 2018424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jan 19, 2018EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Dec 28, 2017F-3 →REGISTEREDF-3 registration — capacity to sell shares, not a sale yet
Oct 31, 2017424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jul 26, 2017424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
BLRX offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes — EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full BLRX workspace →
BLRX offering FAQ

When did BLRX last execute an offering?

Per SEC filings, BioLineRx Ltd.'s most recent priced offering document is a 424B5 filed 2026-08-31. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did BLRX last announce or register an offering?

The most recent registration is a F-1 filed 2026-09-25. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.

Free to use. No account, no card.